HCW Biologics issues 71,000 shares to Armistice upon exercise of pre-funded warrants

HCW Biologics Inc.

On May 28, 2025, Armistice exercised pre-funded warrants for 71,000 shares at $0.0001/share, issued May 29.
Prior exercises: 177,140 shares on May 15 and 126,000 shares on May 22 from the same warrant grant.
Remaining pre-funded warrants held by Armistice now cover 139,000 shares of common stock.
Warrants originated from a Securities Purchase Agreement entered into on May 13, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.